Literature DB >> 18299178

Combination of Pluronic/Vitamin E TPGS as a potential inhibitor of drug precipitation.

Wei-Guo Dai1, Liang C Dong, Shu Li, Zhengyu Deng.   

Abstract

In this study, we screened surfactants and their combinations at low concentrations as potentially potent inhibitors of drug precipitation in an aqueous medium. Nine surfactants (including Pluronic F127, Pluronic F108, and Pluronic F68) were evaluated at concentrations below their critical micelle concentrations (CMCs) using an in vitro precipitation assay. A model compound used in this study showed a sharp pH-dependent solubility profile and was much more soluble in simulated gastric fluid (SGF) (pH 1.2) than in simulated intestinal fluid (SIF) (pH 7.4). The compound was first dissolved in SGF with each surfactant, and the solutions were dispensed into the wells of a 96-well microtiter plate by a TECAN robot and diluted 10-fold with SIF. After a preset incubation time at room temperature, the solutions were filtrated through a 96-well filter plate, and the compound concentration in the filtrate was measured using an HPLC method. At concentrations below their CMCs, Pluronic F127 and Pluronic F108, but not Pluronic F68, inhibited the compound precipitation in SIF. Combinations of Pluronic F127 or Pluronic F108 with Vitamin E TPGS showed significantly stronger inhibition than the individual surfactants, indicating synergistic effects on inhibition of drug precipitation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18299178     DOI: 10.1016/j.ijpharm.2007.12.015

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

1.  Preparation and in-vitro/in-vivo characterization of trans-resveratrol nanocrystals for oral administration.

Authors:  Sandeep K Singh; Vishal Makadia; Shweta Sharma; Mamunur Rashid; Sudhir Shahi; Prabhat R Mishra; Mohammed Wahajuddin; Jiaur R Gayen
Journal:  Drug Deliv Transl Res       Date:  2017-06       Impact factor: 4.617

2.  Stabilized oral nanostructured lipid carriers of Adefovir Dipivoxil as a potential liver targeting: Estimation of liver function panel and uptake following intravenous injection of radioiodinated indicator.

Authors:  Shady M Abd El-Halim; Ghada A Abdelbary; Maha M Amin; Mohamed Y Zakaria; Hesham A Shamsel-Din; Ahmed B Ibrahim
Journal:  Daru       Date:  2020-06-20       Impact factor: 3.117

3.  Raloxifene-loaded SLNs with enhanced biopharmaceutical potential: QbD-steered development, in vitro evaluation, in vivo pharmacokinetics, and IVIVC.

Authors:  Atul Jain; Teenu Sharma; Rajendra Kumar; O P Katare; Bhupinder Singh
Journal:  Drug Deliv Transl Res       Date:  2021-05-08       Impact factor: 4.617

4.  Pluronic F127 and D-α-Tocopheryl Polyethylene Glycol Succinate (TPGS) Mixed Micelles for Targeting Drug Delivery across The Blood Brain Barrier.

Authors:  Xin Meng; Jiansheng Liu; Xiangrong Yu; Jiajia Li; Xiaotong Lu; Teng Shen
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

5.  Enhanced oral bioavailability of valsartan using a polymer-based supersaturable self-microemulsifying drug delivery system.

Authors:  Dong Woo Yeom; Bo Ram Chae; Ho Yong Son; Jin Han Kim; Jun Soo Chae; Seh Hyon Song; Dongho Oh; Young Wook Choi
Journal:  Int J Nanomedicine       Date:  2017-05-08

6.  Poloxamer-Based Thermoreversible Gel for Topical Delivery of Emodin: Influence of P407 and P188 on Solubility of Emodin and Its Application in Cellular Activity Screening.

Authors:  Eunmi Ban; Mijung Park; Seonghee Jeong; Taekhyun Kwon; Eun-Hee Kim; Kiwon Jung; Aeri Kim
Journal:  Molecules       Date:  2017-02-07       Impact factor: 4.411

7.  Poloxamer-188 and d-α-Tocopheryl Polyethylene Glycol Succinate (TPGS-1000) Mixed Micelles Integrated Orodispersible Sublingual Films to Improve Oral Bioavailability of Ebastine; In Vitro and In Vivo Characterization.

Authors:  Nayyer Islam; Muhammad Irfan; Salah-Ud-Din Khan; Haroon Khalid Syed; Muhammad Shahid Iqbal; Ikram Ullah Khan; Amina Mahdy; Mohamed Raafat; Mohammad Akbar Hossain; Sana Inam; Rabia Munir; Memoona Ishtiaq
Journal:  Pharmaceutics       Date:  2021-01-04       Impact factor: 6.321

8.  Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy: in-vitro optimization and ex-vivo assessment.

Authors:  Eman Abd-Elhakeem; Mohamed El-Nabarawi; Rehab Shamma
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

Review 9.  Fundamental aspects of solid dispersion technology for poorly soluble drugs.

Authors:  Yanbin Huang; Wei-Guo Dai
Journal:  Acta Pharm Sin B       Date:  2013-12-05       Impact factor: 11.413

10.  Polymer⁻Surfactant System Based Amorphous Solid Dispersion: Precipitation Inhibition and Bioavailability Enhancement of Itraconazole.

Authors:  Disang Feng; Tingting Peng; Zhengwei Huang; Vikramjeet Singh; Yin Shi; Ting Wen; Ming Lu; Guilan Quan; Xin Pan; Chuanbin Wu
Journal:  Pharmaceutics       Date:  2018-04-24       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.